Streetbeat News

Analyst Ratings

CSR

Compass Point analyst Merrill Ross has upgraded Centerspace (NYSE:CSR) from Neutral to Buy and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:53 pm

BLMN

Barclays analyst Jeffrey Bernstein has maintained an Overweight rating on Bloomin Brands (NASDAQ:BLMN) but lowered the price target from $28 to $27.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:52 pm

CCCC

Morgan Stanley analyst Terence Flynn has upgraded C4 Therapeutics from Underweight to Equal-Weight, but lowered the price target from $3 to $1.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:51 pm

ALGT

Barclays analyst Brandon Oglenski maintains an Equal-Weight rating on Allegiant Travel (NASDAQ:ALGT) and lowers the price target from $75 to $65.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:50 pm

KTOS

Raymond James analyst Brian Gesuale maintains an Outperform rating on Kratos Defense & Security (NASDAQ:KTOS) and raises the price target from $17 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:48 pm

GFL

Raymond James analyst Patrick Tyler Brown maintains an Outperform rating on GFL Environmental (NYSE:GFL) but has lowered the price target from $41 to $35.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:46 pm

CGNX

Raymond James analyst Brian Gesuale maintains a Strong Buy rating on Cognex (NASDAQ:CGNX) but lowers the price target from $65 to $60.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:44 pm

ALL

Raymond James analyst C. Gregory Peters maintains a Strong Buy rating on Allstate (NYSE:ALL) and raises the price target from $145 to $155.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:41 pm

BLMN

Raymond James analyst Brian Vaccaro has downgraded Bloomin Brands (NASDAQ:BLMN) from Strong Buy to Outperform and lowered the price target from $29 to $28.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:38 pm

XXII

22nd Century Group (NASDAQ:XXII) reported Q3 losses of $(3.68) per share, missing the analyst consensus estimate of $(0.91) by 304.4%. This is a 291.49% decrease from the same period last year. The company also reported quarterly sales of $17.80 million, missing the analyst consensus estimate of $20.05 million by 11.22%. This is a 8.17% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:34 pm